GJA1 and heart failure: The drug reverses heart failure metabolic dysfunction by promoting fatty acid/glucose utilization, inhibiting inefficient glycolysis, and restoring mitochondrial oxidation, addressing energy deficits and Cx43-dependent electrical-mechanical synchronization.